Cost Effectiveness Decisions Playing Greater Role In Off-Label Coverage
Executive Summary
The role of cost analysis in the context of comparative effectiveness research has been hotly contested, but cost effectiveness is already gaining importance as a factor in how third-party payers run Medicare and Medicaid prescription drug plans